Synonym: 4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
CAS Number: 75695-93-1
Empirical Formula (Hill Notation): C19H21N3O5
Molecular Weight: 371.39
MDL Number: MFCD00153820
Linear Formula: C19H21N3O5
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts I6658-5MG.
| assay |
≥98% (HPLC) |
| color |
yellow |
| description |
Store under nitrogen |
| form |
solid |
| InChI |
1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3 |
| InChI key |
HMJIYCCIJYRONP-UHFFFAOYSA-N |
| originator |
Novartis |
| Quality Level |
100  |
| SMILES string |
COC(=O)C1=C(C)NC(C)=C(C1c2cccc3nonc23)C(=O)OC(C)C |
| solubility |
DMSO: >10 mg/mL |
| storage temp. |
2-8°C |
| Application: |
Isradipine has been used to explore neuroprotective activity. |
| Biochem/physiol Actions: |
Isradipine is considered as an active calcium channel blocker, used to treat hypertension. |
| Biochem/physiol Actions: |
L-type calcium channel blocker (also referred to as dihydropyridine-type calcium channel blocker); antihypertensive. |
| Biochem/physiol Actions: |
L-type calcium channel blocker; antihypertensive. |
| Features and Benefits: |
This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
5, 25 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |